van Leeuwen RWF - Search Results

1

The added value of H₂ antagonists in premedication regimens during paclitaxel treatment.

Cox JM, van Doorn L, Malmberg R, Oomen-de Hoop E, Bosch TM, van den Bemt PMLA, Boere IA, Jager A, Mathijssen RHJ, van Leeuwen RWF. Cox JM, et al. Among authors: van leeuwen rwf. Br J Cancer. 2021 May;124(10):1647-1652. doi: 10.1038/s41416-021-01313-0. Epub 2021 Mar 24. Br J Cancer. 2021. PMID: 33762718 Free PMC article. Clinical Trial.

2

Prevalence of potential drug-drug interactions in cancer patients treated with oral anticancer drugs.

van Leeuwen RW, Brundel DH, Neef C, van Gelder T, Mathijssen RH, Burger DM, Jansman FG. van Leeuwen RW, et al. Br J Cancer. 2013 Mar 19;108(5):1071-8. doi: 10.1038/bjc.2013.48. Epub 2013 Feb 14. Br J Cancer. 2013. PMID: 23412102 Free PMC article.

3

Drug-drug interactions with tyrosine-kinase inhibitors: a clinical perspective.

van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG. van Leeuwen RW, et al. Lancet Oncol. 2014 Jul;15(8):e315-26. doi: 10.1016/S1470-2045(13)70579-5. Lancet Oncol. 2014. PMID: 24988935 Review.

4

Drug interactions between tyrosine-kinase inhibitors and acid suppressive agents: more than meets the eye-Authors' reply.

van Leeuwen RW, van Gelder T, Mathijssen RH, Jansman FG. van Leeuwen RW, et al. Lancet Oncol. 2014 Oct;15(11):e470-1. doi: 10.1016/S1470-2045(14)70459-0. Lancet Oncol. 2014. PMID: 25281462 No abstract available.

5

Drug-drug interactions in patients treated for cancer: a prospective study on clinical interventions.

van Leeuwen RWF, Jansman FGA, van den Bemt PMLA, de Man F, Piran F, Vincenten I, Jager A, Rijneveld AW, Brugma JD, Mathijssen RHJ, van Gelder T. van Leeuwen RWF, et al. Among authors: van gelder t, van den bemt pmla. Ann Oncol. 2015 May;26(5):992-997. doi: 10.1093/annonc/mdv029. Epub 2015 Jan 26. Ann Oncol. 2015. PMID: 25628444 Free article.

6

Reply to the letter to the editor 'potential clinical relevant drug-drug interactions: comparison between different compendia, do we have a validated method?' by Conde-Estévez et al.

van Leeuwen RWF, Mathijssen RHJ, Jansman FGA, van Gelder T. van Leeuwen RWF, et al. Among authors: van gelder t. Ann Oncol. 2015 Jun;26(6):1272-1273. doi: 10.1093/annonc/mdv169. Epub 2015 Apr 6. Ann Oncol. 2015. PMID: 25846553 Free article. No abstract available.

7

Influence of the Acidic Beverage Cola on the Absorption of Erlotinib in Patients With Non-Small-Cell Lung Cancer.

van Leeuwen RW, Peric R, Hussaarts KG, Kienhuis E, IJzerman NS, de Bruijn P, van der Leest C, Codrington H, Kloover JS, van der Holt B, Aerts JG, van Gelder T, Mathijssen RH. van Leeuwen RW, et al. J Clin Oncol. 2016 Apr 20;34(12):1309-14. doi: 10.1200/JCO.2015.65.2560. Epub 2016 Feb 8. J Clin Oncol. 2016. PMID: 26858332 Clinical Trial.

8

Tyrosine Kinase Inhibitors and Proton Pump Inhibitors: An Evaluation of Treatment Options.

van Leeuwen RWF, Jansman FGA, Hunfeld NG, Peric R, Reyners AKL, Imholz ALT, Brouwers JRBJ, Aerts JG, van Gelder T, Mathijssen RHJ. van Leeuwen RWF, et al. Among authors: van gelder t. Clin Pharmacokinet. 2017 Jul;56(7):683-688. doi: 10.1007/s40262-016-0503-3. Clin Pharmacokinet. 2017. PMID: 28101705 Free PMC article.

9

Factors Affecting the Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer.

Hussaarts KGAM, van Leeuwen RWF, Mathijssen RHJ. Hussaarts KGAM, et al. Among authors: van leeuwen rwf. JAMA Oncol. 2018 Feb 1;4(2):263-264. doi: 10.1001/jamaoncol.2016.7019. JAMA Oncol. 2018. PMID: 29098281 No abstract available.

10

Influence of Enzalutamide on Cabazitaxel Pharmacokinetics: a Drug-Drug Interaction Study in Metastatic Castration-resistant Prostate Cancer (mCRPC) Patients.

Belderbos BPS, Bins S, van Leeuwen RWF, Oomen-de Hoop E, van der Meer N, de Bruijn P, Hamberg P, Overkleeft ENM, van der Deure WM, Lolkema MP, de Wit R, Mathijssen RHJ. Belderbos BPS, et al. Among authors: van leeuwen rwf, van der meer n, van der deure wm. Clin Cancer Res. 2018 Feb 1;24(3):541-546. doi: 10.1158/1078-0432.CCR-17-2336. Epub 2017 Nov 17. Clin Cancer Res. 2018. PMID: 29150561

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

37 results

Search Page